Ascendis Pharma A/S (ASND) — Stock Score Summary

Ascendis Pharma A/S (ASND) has a MoatMap StockRank of 66/100 based on Quality (51/100), Value (38/100), and Momentum (59/100) factor scores. The current signal is BUY. Ascendis Pharma is a commercial-stage biopharma company with a proprietary TransCon platform. While technologically advanced, it is not a CDMO and carries significant clinical, regulatory, and commercial execution risks that violate our Terry Smith quality criteria.

Ascendis Pharma A/S is a biopharmaceutical company focused on developing innovative prodrug therapies for rare diseases using its proprietary TransCon technology platform. Its competitive moat is derived from this unique and versatile technology, which enables the creation of sustained-release drug candidates with improved efficacy and safety profiles. The company is a specialized biotech firm, aiming to redefine standards of care for patients with significant unmet medical needs.

Key Financial Metrics

Price$216.79
Market Cap$14.7B
P/E (TTM)24.90
P/E (Forward)19.99
Price/Book23.92
Return on Equity332.7%
Return on Invested Capital-56.6%
Debt/Equity183.75
Gross Margin89.0%
Operating Margin10.1%
Revenue Growth144.3%
Free Cash Flow$118M

Ascendis Pharma A/S operates in the Biotechnology industry, part of the Healthcare sector (Denmark).

Frequently Asked Questions

What is Ascendis Pharma A/S’s (ASND) StockRank?
MoatMap’s StockRank for Ascendis Pharma A/S (ASND) is 66/100, with a Buy signal. It is a composite of Quality (51), Value (38), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ascendis Pharma A/S have an economic moat?
Ascendis Pharma A/S (ASND) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ascendis Pharma A/S a buy, hold, or sell?
MoatMap’s current signal for Ascendis Pharma A/S (ASND) is Buy, based on a StockRank of 66/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ascendis Pharma A/S in?
Ascendis Pharma A/S (ASND) operates in the Healthcare sector, specifically the Biotechnology industry (Denmark).
Browse all ranked stocksASND deep dive reportAI ChampionsHow we score stocksSense-check another stock